Nokea
What is the condition where the blood flow through the coronary arteries is reduced or blocked, leading to chest pain or heart attack?
- A. Coronary artery disease
- B. Atherosclerosis
- C. Pulmonary embolism
- D. Pulmonary hypertension
Correct Answer: A
Rationale: The correct answer is A: Coronary artery disease. Coronary artery disease is the condition where there is reduced blood flow or blockage in the coronary arteries supplying blood to the heart muscle. This can lead to chest pain (angina) or a heart attack. Atherosclerosis is a buildup of plaque in the arteries, which is a major cause of coronary artery disease. Pulmonary embolism is a blockage in the arteries in the lungs, not the coronary arteries supplying the heart. Pulmonary hypertension is high blood pressure in the arteries of the lungs, not related to the coronary arteries. Therefore, the correct answer is A as it directly relates to the specific condition described in the question.
You may also like to solve these questions
What is a condition where the lung's alveoli are permanently enlarged and damaged, leading to shortness of breath?
- A. Emphysema
- B. Bronchitis
- C. Atelectasis
- D. Pulmonary fibrosis
Correct Answer: A
Rationale: The correct answer is A: Emphysema. Emphysema is a condition where the lung's alveoli are permanently enlarged and damaged, causing shortness of breath. This occurs due to the destruction of the alveoli walls, leading to decreased surface area for oxygen exchange. This results in difficulty breathing and reduced oxygen supply to the body. Bronchitis (B) is inflammation of the bronchial tubes, not alveoli damage. Atelectasis (C) is the collapse of lung tissue, not enlargement. Pulmonary fibrosis (D) is scarring of lung tissue, not alveoli enlargement.
The client on spironolactone (Aldactone) has a potassium level of 5.6 mEq/L. What is the nurse's priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer potassium supplements.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct Answer: A
Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.6 mEq/L is elevated (normal range is 3.5-5.0 mEq/L). Spironolactone is a potassium-sparing diuretic, so the priority action is to hold the medication to prevent further elevation of potassium levels, which can lead to serious cardiac arrhythmias. Notifying the healthcare provider is crucial for further management. Administering potassium supplements (B) would further increase potassium levels. Continuing spironolactone as ordered (C) would exacerbate hyperkalemia. Increasing the dose of spironolactone (D) would be contraindicated in this situation.
What is a condition where the lung's air sacs (alveoli) are damaged and enlarged, leading to breathlessness?
- A. Emphysema
- B. Chronic bronchitis
- C. Asthma
- D. Pulmonary fibrosis
Correct Answer: A
Rationale: The correct answer is A: Emphysema. Emphysema is a condition where the lung's air sacs are damaged and enlarged, leading to breathlessness. This occurs due to the destruction of the alveoli walls, causing reduced surface area for gas exchange and airflow obstruction. Chronic bronchitis (B) involves inflammation of the bronchial tubes, not alveoli damage. Asthma (C) is characterized by airway inflammation and bronchoconstriction, not alveoli damage. Pulmonary fibrosis (D) is scarring of lung tissue, not enlargement of the alveoli.
Which of the following is a type of heart valve disease where the aortic valve becomes narrowed, restricting blood flow from the heart to the rest of the body?
- A. Aortic stenosis
- B. Mitral stenosis
- C. Tricuspid regurgitation
- D. Pulmonary hypertension
Correct Answer: A
Rationale: The correct answer is A: Aortic stenosis. Aortic stenosis is a condition where the aortic valve narrows, impeding blood flow from the heart to the body, leading to symptoms like chest pain and shortness of breath. The other choices are incorrect because:
B: Mitral stenosis involves narrowing of the mitral valve, affecting blood flow between the left atrium and ventricle.
C: Tricuspid regurgitation is when the tricuspid valve leaks, causing blood to flow backward into the heart.
D: Pulmonary hypertension is a condition characterized by high blood pressure in the arteries of the lungs, unrelated to aortic valve narrowing.
You make a home visit to evaluate a hypertensive patient who has been taking enalapril (Vasotec) for 3 weeks. Which information indicates that you need to contact the physician about a change in the drug therapy?
- A. Patient complains of frequent urination.
- B. Patient's blood pressure is 138/86.
- C. Patient coughs often during the visit.
- D. Patient complains of occasional dizziness.
Correct Answer: C
Rationale: A persistent cough is a common side effect of ACE inhibitors like enalapril, and it may warrant a change in medication.